Tim P. Green

1.5k citations

14 papers · 1.2k indexed · h-index 13

Impact in

Oncology top 5%
- HER2/EGFR in Cancer Research
- Bone health and treatments
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research

Papers in

Immunology and Allergy 4
- Cell Adhesion Molecules Research 4
Cell Biology 4
- Cellular Mechanics and Interactions 3

Co-authors: Patrick A. Plé Gerard Costello Jon Curwen Laurent Hennequin J M Allen L. Morgan Robert I. Nicholson Stephen Hiscox
Journals: Cancer Research (3 papers)Journal of Medicinal Chemistry (2 papers)Molecular Cancer Research (1 paper)Molecular Oncology (1 paper)Journal of Thoracic Oncology (1 paper)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Tim P. Green

14 papers receiving 1.2k citations

Peers

Replace Gretchen M. Unger with:

Gretchen M. Unger United States

Laurie M. Strawn United States

Babita Saigal United States

Wells S. Brown United States

Alastair J. King United States

Kenneth R. LaMontagne United States

Rumey C. Ishizawar United States

Andreas Menrad Germany

Mike F. Burbridge France

Julie Litz United States

Tim P. Green relative to Gretchen M. Unger United States Gretchen M. Unger's profile →

Citations per field

00.5×1.5×2.0×

Gretchen M. Unger · 1×

×1.2 504/438

ONCOL

×2.0 92/45

IA

×1.4 118/85

HEMAT

×0.6 699/1k

MB

×0.7 133/181

CR

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by Tim P. Green

Since Specialization

Citations

This map shows the geographic impact of Tim P. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim P. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim P. Green more than expected).

Fields of papers citing papers by Tim P. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim P. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim P. Green. The network helps show where Tim P. Green may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tim P. Green, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim P. Green Line = papers co-authored together Tim P. Green links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Src Family Kinase Inhibitor Saracatinib (AZD0530) Impairs Oxaliplatin Uptake in Colorectal Cancer Cells and Blocks Organic Cation Transporters Cancer Research ·Christopher J. Morrow, Mohammad A. Ghattas, Christopher G. Smith, Heinz Bönisch, Richard A. Bryce, D. Mark Hickinson, Tim P. Green, Caroline Dive	2010	24
2	The Src Inhibitor AZD0530 Blocks Invasion and May Act as a Radiosensitizer in Lung Cancer Cells Journal of Thoracic Oncology ·Phillip R. Purnell, Philip C. Mack, Clifford G. Tepper, Christopher P. Evans, Tim P. Green, Paul H. Gumerlock, Primo N. Lara, David R. Gandara, Hsing-Jien Kung, Oliver Gautschi	2009	41
3	Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function Journal of Cancer Science & Therapy ·Amanda G. Ammer, Laura C. Kelley, Karen E. Hayes, Jason V. Evans, Kolej Komuniti Jelebu, Karen H. Martin, Barbara Frederick, 長坂秀雄, David Raben, Paul Elvin, Tim P. Green, Scott A. Weed	2009	62
4	Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530 Molecular Oncology ·Tim P. Green, Petra Krömer, P. Lista, Jon Curwen, Vivien N. Jacobs, J M Allen, Armelle Logié, Judith Hargreaves, D. Mark Hickinson, Robert W. Wilkinson, Paul Elvin, Brigitte Boyer, Neil O. Carragher, Patrick A. Plé, Alun Bermingham, Geoffrey A. Holdgate, Walter H.J. Ward, Laurent Hennequin, Barry R. Davies, Gerard Costello	2009	176
5	The Src Inhibitor AZD0530 Reversibly Inhibits the Formation and Activity of Human Osteoclasts Molecular Cancer Research ·Teun J. de Vries, Margriet G. Mullender, Marion A. van Duin, Cornelis M. Semeins, Neil H. James, Tim P. Green, Vincent Everts, Jenneke Klein‐Nulend	2009	52
6	Regulation of Id1 Expression by Src: Implications for Targeting of the Bone Morphogenetic Protein Pathway in Cancer Cancer Research ·Oliver Gautschi, Clifford G. Tepper, Phillip R. Purnell, Yoshihiro Izumiya, Christopher P. Evans, Tim P. Green, Pierre Y. Desprez, Primo N. Lara, David R. Gandara, Philip C. Mack, Hsing-Jien Kung	2008	67
7	A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model Carcinogenesis ·Bryan Serrels, Alan Serrels, Susan Mason, Christine Baldeschi, G H S Ashton, Marta Canel, Lorna Mackintosh, Brendan Doyle, Tim P. Green, Margaret C. Frame, Owen J. Sansom, Valerie G. Brunton	2008	28
8	Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells Clinical & Experimental Metastasis ·Stephen Hiscox, Nicola Jordan, L. Morgan, Tim P. Green, Robert I. Nicholson	2007	53
9	N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor Journal of Medicinal Chemistry ·Laurent Hennequin, J M Allen, J. Breed, Jon Curwen, Michael Fennell, Tim P. Green, Christine Lambert‐van der Brempt, Rémy Morgentin, Richard A. Norman, Annie Olivier, Ludovic R. Otterbein, Patrick A. Plé, Nicolas Warin, Gerard Costello	2006	283
10	Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor–positive human breast cancer cells Molecular Cancer Therapeutics ·Matthew H. Herynk, Amanda Beyer, Yukun Cui, Heidi L. Weiss, Elizabeth Anderson, Tim P. Green, Suzanne A.W. Fuqua	2006	51
11	Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells Breast Cancer Research and Treatment ·Stephen Hiscox, L. Morgan, Tim P. Green, Denise Barrow, Julia M.W. Gee, Robert I. Nicholson	2005	201
12	Pharmacokinetics, tissue distribution and anti-tumor activity of the Src/Abl kinase inhibitor AZD0530 in a rat xenograft model Cancer Research ·Armelle Logié, Paul Martin, E. A. Partridge, Osamu Hoshimo, P. Lista, Tim P. Green	2005	2
13	Discovery of a New Class of Anilinoquinazoline Inhibitors with High Affinity and Specificity for the Tyrosine Kinase Domain of c-Src Journal of Medicinal Chemistry ·Patrick A. Plé, Tim P. Green, Laurent Hennequin, Jon Curwen, Michael Fennell, J M Allen, Christine Lambert‐van der Brempt, Gerard Costello	2004	139
14	Specific polyclonal and monoclonal antibody prevents paraquat accumulation into rat lung slices Biochemical Pharmacology ·Chae Wook Lee, Tim P. Green, Avsar Asan, Parvati Bista, I. Wyatt, Lewis L. Smith	1987	12

About Tim P. Green

Tim P. Green is a scholar working on Immunology and Allergy, Cell Biology, Genetics, Oncology and Hematology, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (4 papers), Cellular Mechanics and Interactions (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), TGF-β signaling in diseases (2 papers), Quinazolinone synthesis and applications (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Oncology (504 citations), Immunology and Allergy (92 citations), Hematology (118 citations), Molecular Biology (699 citations) and Cancer Research (133 citations). Tim P. Green has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Patrick A. Plé, Gerard Costello, Jon Curwen, Laurent Hennequin, J M Allen, L. Morgan, Robert I. Nicholson, Stephen Hiscox, Michael Fennell and Christine Lambert‐van der Brempt. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry, Molecular Cancer Research, Molecular Oncology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact